Richtlijnen - AZ Sint-Lucas

Algoritme voor behandeling HCC ( JCO, 2010, vol.28, Nr. 25, september 2010: Thomas M., Jaffe D.,
Choti M.et al.)
5.7 Referenties
Hepatology, 2003 Feb;37(2):429-42.Systematic review of randomized trials for unresectable
hepatocellular carcinoma: Chemoembolization improves survival. Llovet JM, Bruix J.
N. Engl. J. Med., 2008, Jul 24;359(4):378-90.Sorafenib in advanced hepatocellular
carcinoma.Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A,
Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF,
Borbath I, Häussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J; SHARP Investigators
Study Group.
Lancet Oncology, 2009 Jan;10(1):35-43. Epub 2008 Dec 4. Predicting survival after liver
transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a
retrospective, exploratory analysis. Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M,
Mariani L, Camerini T, Roayaie S, Schwartz ME, Grazi GL, Adam R, Neuhaus P, Salizzoni M, Bruix J,
Forner A, De Carlis L, Cillo U, Burroughs AK, Troisi R, Rossi M, Gerunda GE, Lerut J, Belghiti J, Boin
I, Gugenheim J, Rochling F, Van Hoek B, Majno P; Metroticket Investigator Study Group.